glyburide has been researched along with Arteriosclerosis, Coronary in 8 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic and coronary hemodynamics were assessed in 20 patients before and after K(ATP) channel inhibition with graded intracoronary glibenclamide infusions (4, 16, and 40 microg/min), in an angiographically smooth or mildly stenosed coronary artery following successful elective percutaneous coronary intervention to another vessel." | 2.70 | Effect of ATP-sensitive potassium channel inhibition on resting coronary vascular responses in humans. ( Farouque, HM; Meredith, IT; Skyrme-Jones, RA; Worthley, SG; Zhang, MJ, 2002) |
| "Treatment with glyburide is associated with increased all-cause and cardiovascular mortality in patients with T2DM." | 1.46 | All-Cause and Cardiovascular Mortality following Treatment with Metformin or Glyburide in Patients with Type 2 Diabetes Mellitus. ( Esteghamati, A; Heidari, B; Larry, M; Mansournia, MA; Nakhjavani, M; Nargesi, AA; Rabizadeh, S; Raee, MR; Zarifkar, M, 2017) |
| "Initiating treatment of type 2 diabetes with glibenclamide or glipizide is associated with increased risk of CAD in comparison to gliclazide or glimepiride." | 1.35 | Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study. ( Mogensen, CE; Sadikot, SM, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giblett, JP | 1 |
| Axell, RG | 1 |
| White, PA | 1 |
| Clarke, SJ | 1 |
| McCormick, L | 1 |
| Read, PA | 1 |
| Reinhold, J | 1 |
| Brown, AJ | 1 |
| O'Sullivan, M | 1 |
| West, NE | 1 |
| Dutka, DP | 1 |
| Hoole, SP | 1 |
| Zheng, M | 1 |
| Li, LZ | 1 |
| Jiang, ZA | 1 |
| Li, LH | 1 |
| Feng, YG | 1 |
| Fu, XH | 1 |
| Raee, MR | 1 |
| Nargesi, AA | 1 |
| Heidari, B | 1 |
| Mansournia, MA | 1 |
| Larry, M | 1 |
| Rabizadeh, S | 1 |
| Zarifkar, M | 1 |
| Esteghamati, A | 1 |
| Nakhjavani, M | 1 |
| Sadikot, SM | 1 |
| Mogensen, CE | 1 |
| Farouque, HM | 2 |
| Worthley, SG | 2 |
| Meredith, IT | 2 |
| Ferreira, BM | 1 |
| Moffa, PJ | 1 |
| Falcão, A | 1 |
| Uchida, A | 1 |
| Camargo, P | 1 |
| Pereyra, P | 1 |
| Soares, PR | 1 |
| Hueb, W | 1 |
| Ramires, JA | 1 |
| O'Brien, RC | 1 |
| Luo, M | 1 |
| Skyrme-Jones, RA | 1 |
| Zhang, MJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Investigation Into Cardioprotective Effect of Glucagon-like Peptide-1 and it's Mechanism of Action During Myocardial Ischaemia[NCT02128022] | Phase 1 | 32 participants (Actual) | Interventional | 2014-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for glyburide and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Coronary Vessels; Echocardiogra | 2016 |
Effect of ATP-sensitive potassium channel inhibition on resting coronary vascular responses in humans.
Topics: Adenosine; Adenosine Triphosphate; Blood Flow Velocity; Blood Glucose; Coronary Angiography; Coronar | 2002 |
6 other studies available for glyburide and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
[Effects of different sulfonylureas on the warm-up phenomenon in diabetes patients with coronary artery disease].
Topics: Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Diabetes Mel | 2017 |
All-Cause and Cardiovascular Mortality following Treatment with Metformin or Glyburide in Patients with Type 2 Diabetes Mellitus.
Topics: Aged; Cardiovascular Diseases; Cause of Death; Cohort Studies; Coronary Angiography; Coronary Artery | 2017 |
Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study.
Topics: Adult; Case-Control Studies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathi | 2008 |
Effect of ATP-sensitive potassium channel inhibition on coronary metabolic vasodilation in humans.
Topics: Adenosine Triphosphate; Aged; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Cardiac Pacin | 2004 |
The effects of glibenclamide, a K(ATP) channel blocker, on the warm-up phenomenon.
Topics: Analysis of Variance; Angina Pectoris; Chi-Square Distribution; Chronic Disease; Coronary Angiograph | 2005 |
The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.
Topics: Administration, Oral; Adult; Antioxidants; Ascorbic Acid; Coronary Artery Disease; Diabetes Mellitus | 1997 |